Symtomax
PrivateCompany Overview
Symtomax is a pharmaceutical and agricultural company that specializes in the cultivation, production, and distribution of medical-grade cannabis oil and cannabinoid-based products.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Pharma Supply Chain
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
medical cannabiscannabis cultivationmedicinal cannabis oilcannabinoid productsmedical cannabis supplierGACPgood agricultural and collection practicespharma supply chainmedical grade cannabiscannabis pharmacannabis biotechmedical cannabis exportcannabis extraction
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Symtomax Comparables
Compare Symtomax with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AceCann | 90% | |
| GreenBE Pharma | 89% | |
| Linneo Health | 87% | |
Symtomax Funding Rounds
Historical fundraising activity
Symtomax Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Symtomax's valuation, stock price, and market status.